SCHEMBL9142138

SCHEMBL9142138

O=Cc1cccc(C=O)c1CCCCCCCCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 11/20 0.50
MAPT P10636 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HDAC1 Q13547 1/20 0.45
MAOA P21397 1/20 0.44
CDK1 P06493 1/20 0.43
CYP2D6 P10635 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ACHE P22303 1/20 0.42
SGMS1 Q86VZ5 1/20 0.42
SGMS2 Q8NHU3 1/20 0.42
MAOB P27338 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7397839 0.83 TRIM24 (0.48) SIGMAR1MAPTRXFP1HDAC1CDK1
SCHEMBL7091261 0.81 SIGMAR1 (0.50) SIGMAR1MAPTRXFP1MAOACDK1
SCHEMBL14471931 0.81 SIGMAR1 (0.46) SIGMAR1MAPTRXFP1MAOACYP2D6
SCHEMBL9491986 0.78 BID (0.47) SIGMAR1MAPTRXFP1MAOACDK1
SCHEMBL9428004 0.77 ALDH1A1 (0.65) SIGMAR1MAPTCDK1MEN1LMNA
SCHEMBL6000358 0.77 ALDH1A1 (0.65) SIGMAR1MAPTCDK1MEN1LMNA
SCHEMBL10648882 0.75 ALDH1A1 (0.67) MAPTCDK1MEN1LMNAKMT2A
SCHEMBL9099042 0.75 TRIM24 (0.52) MAPTHDAC1MEN1LMNATHRB
SCHEMBL9502638 0.75 KDM4E (0.44) SIGMAR1MAPTRXFP1MEN1KMT2A
SCHEMBL1433686 0.74 SIGMAR1 (0.71) SIGMAR1MAPTRXFP1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428065-A Treating central nervous system disorders LILLY INDUSTRIES LIMITED (GB) 1995-06-27 US disclosed
EP-0645370-A1 Substituted m-xylylene diamines for the treatment of diseases of the central nervous system LILLY INDUSTRIES LIMITED (GB) 1995-03-29 EP disclosed